Home LiteratureArticle Details
PMID: 8454352 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock.

Infection and immunity ·Vol. 61 ·No. 4 ·1993-04-00 ·Pages 1474-81

Barton PA, Warren JS

Abstract

Patients with disseminated Neisseria meningitidis infections (meningococcemia) suffer from a fulminant shock syndrome that is accompanied by extraordinarily high concentrations in serum of tumor necrosis factor (TNF). People with homozygous deficiencies of late complement components (C5, C6, C7, and C8) experience a high incidence of disseminated neisserial infections yet suffer from an attenuated form of the disease. The mechanisms that account for this disparity in host response are unclear, but they may in part be related to differences in the systemic TNF response that are modulated by terminal complement components (C5 to C9). The role of C5 in the modulation of the systemic endotoxin-induced TNF response was studied with matched strains of C5-deficient (B10 D2/Osn) and complement-sufficient (B10 D2/Nsn) mice. Following lipopolysaccharide (LPS) administration, complement-sufficient mice exhibited more rapid increases in pulmonary and hepatic vascular permeabilities than did C5-deficient controls. Complement-sufficient mice developed acute passive hepatic congestion, they appeared more ill than C5-deficient mice, and they exhibited a twofold greater rise in serum TNF activity compared with that by C5-deficient mice. C5-deficient mice reconstituted with normal serum before an LPS injection exhibited pulmonary and hepatic vascular permeability increases and serum TNF levels approaching those observed in complement-sufficient mice. Alveolar and peritoneal macrophages isolated from complement-sufficient and C5-deficient mice and incubated in heat-inactivated serum did not exhibit differences in TNF mRNA expression or secreted TNF activity following stimulation with LPS. However, incubation of macrophages in complement-sufficient mouse serum (before LPS stimulation) resulted in increased TNF mRNA expression and TNF activity compared with those in cells incubated in C5-deficient serum. In vitro studies employing human complement components and peripheral blood monocytes revealed that recombinant C5a, in the presence or absence of LPS, can induce increased concentrations of TNF and that C5b to C9 had no additional modulatory effect on the TNF response. These data suggest that C5 modulates the endotoxin-triggered TNF response. The role of complement components distal to C5 (i.e., C5b to C9) in the endotoxin-triggered TNF response remains unclear.

Related Genes
TNF
MeSH Terms
Animals Base Sequence Complement C5/deficiency,physiology Gene Expression Lipopolysaccharides/toxicity Lung/pathology Macrophages/physiology Mice Mice, Inbred Strains Molecular Sequence Data Monocytes/physiology Neutrophils/physiology Oligodeoxyribonucleotides/chemistry RNA, Messenger/genetics Shock, Septic/pathology,physiopathology Tumor Necrosis Factor-alpha/genetics,metabolism
Chemicals
Complement C5 Lipopolysaccharides Oligodeoxyribonucleotides RNA, Messenger Tumor Necrosis Factor-alpha
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Barton P A
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602.
Warren J S
References (44)
44 references, click to expand
  1. Comparative O2-. responses of lung macrophages and blood phagocytic cells in the rat. Possible relevance to IgA immune complex induced lung injury.
    Lab Invest. 1987 Sep;57(3):311-20 PMID: 3041102
  2. Acute in vivo effects of human recombinant tumor necrosis factor.
    Lab Invest. 1987 Jun;56(6):583-90 PMID: 3599906
  3. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  4. Identification of an inducible endothelial-leukocyte adhesion molecule.
    Proc Natl Acad Sci U S A. 1987 Dec;84(24):9238-42 PMID: 2827173
  5. Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN.
    J Immunol Methods. 1988 Jun 13;110(2):203-7 PMID: 2837516
  6. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.
    J Exp Med. 1988 Jul 1;168(1):443-8 PMID: 3260938
  7. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha.
    J Biol Chem. 1988 Aug 25;263(24):11856-61 PMID: 3261295
  8. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
    J Cell Biol. 1988 Oct;107(4):1269-77 PMID: 3049617
  9. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.
    Proc Natl Acad Sci U S A. 1988 Dec;85(23):9219-23 PMID: 3143114
  10. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta.
    Science. 1989 Mar 17;243(4897):1467-9 PMID: 2648570
  11. Mediator-induced activation of xanthine oxidase in endothelial cells.
    FASEB J. 1989 Nov;3(13):2512-8 PMID: 2806779
  12. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat.
    J Clin Invest. 1989 Dec;84(6):1873-82 PMID: 2531759
  13. The role of the complement system in shock and tissue injury induced by tumour necrosis factor and endotoxin.
    Immunology. 1990 Jul;70(3):309-14 PMID: 2379939
  14. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    J Immunol. 1991 Jul 15;147(2):509-14 PMID: 2071893
  15. Acute immunologic pulmonary alveolitis.
    J Clin Invest. 1974 Aug;54(2):349-57 PMID: 4277008
  16. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.
    J Immunol. 1978 Sep;121(3):851-5 PMID: 211165
  17. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  18. Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.
    Cell. 1980 May;20(1):95-105 PMID: 6893015
  19. Purification and physico-chemical characterization of rabbit tumor necrosis factor.
    J Immunol. 1980 Oct;125(4):1671-7 PMID: 6997383
  20. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.
    Immunopharmacology. 1980 Jun;2(3):201-19 PMID: 6254906
  21. Meningococci.
    Crit Rev Microbiol. 1981;8(3):267-302 PMID: 6781818
  22. Role of oxygen metabolites in immune complex injury of lung.
    J Immunol. 1981 Jun;126(6):2365-9 PMID: 6453163
  23. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.
    J Clin Invest. 1983 Sep;72(3):789-801 PMID: 6886005
  24. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.
    Medicine (Baltimore). 1984 Sep;63(5):243-73 PMID: 6433145
  25. The membrane attack complex.
    Springer Semin Immunopathol. 1984;7(2-3):93-141 PMID: 6387983
  26. Epidermal keratin gene expressed in embryos of Xenopus laevis.
    Proc Natl Acad Sci U S A. 1985 Aug;82(16):5413-7 PMID: 2410923
  27. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  28. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1985 Sep;82(18):6060-4 PMID: 3898078
  29. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
    J Immunol. 1985 Dec;135(6):3972-7 PMID: 2999236
  30. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1985 Dec;82(24):8667-71 PMID: 3866246
  31. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
    J Immunol. 1986 Mar 1;136(5):1680-7 PMID: 3485132
  32. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
    J Exp Med. 1986 Mar 1;163(3):740-5 PMID: 3753996
  33. Stimulation of neutrophils by tumor necrosis factor.
    J Immunol. 1986 Jun 1;136(11):4220-5 PMID: 3009619
  34. An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism.
    J Immunol. 1986 Jun 15;136(12):4548-53 PMID: 3486903
  35. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1363-75 PMID: 3011946
  36. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
  37. Tumor necrosis factor provokes superoxide anion generation from neutrophils.
    Biochem Biophys Res Commun. 1986 Jun 30;137(3):1094-100 PMID: 3015137
  38. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.
    Am J Pathol. 1986 Aug;124(2):179-85 PMID: 3526909
  39. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  40. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.
    J Immunol. 1987 Mar 1;138(5):1469-74 PMID: 3805724
  41. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.
    Lancet. 1987 Feb 14;1(8529):355-7 PMID: 2880163
  42. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    J Immunol. 1987 May 15;138(10):3319-24 PMID: 3494766
  43. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.
    Surg Gynecol Obstet. 1987 May;164(5):415-22 PMID: 3576418
  44. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1).
    Cell. 1987 Dec 4;51(5):813-9 PMID: 3315233
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1993-04-00
Pages
1474-81
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC281388
Subset
IM
Grants
NHLBI NIH HHS · HL-40526 · United States
NHLBI NIH HHS · HL-48287 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]